ライフサイエンスコーパス: carboxyphenyl

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 er of 5alpha-cholestane-3,17-diol with 5-(4'-carboxyphenyl)-10,15,20-triphenylporphin (2-alphabeta, 2

2 on of Cu(NO3)2.2.5H2O with the link bis(4-(4-carboxyphenyl)-1H-pyrazolyl)methane (H2bcppm) and shown

3 ot from [(p-cymene)RuCl(2)](2), sodium 4'-(4-carboxyphenyl)-2,2':6',2''-terpyridine ([Na(+)]tpy-PhCOO

4 azolinones, led to the discovery of (E)-3-(3-carboxyphenyl)-2-(4-cyanostyryl)quinazolin-4(3H)-one (co

5 ZP4 (Zinpyr-4, 9-(o-carboxyphenyl)-2-chloro-5-[2-(bis(2-pyridylmethyl)aminom

6 of six quaternary ammonium salts of 2,4-di-p-carboxyphenyl-2,4-dimethyl pentanone.

7 tely abrogated by a NO quenching agent, 2-(4-carboxyphenyl)-4, 4,5,5-tetramethylimidazoline-1-oxyl 3-

8 ydroxydecanoate and by the NO scavenger 2-(4-carboxyphenyl)-4,4', 5,5'-tetramethylimidazole-1-oxyl-3-

9 not in the presence of the NO scavenger 2-(4-carboxyphenyl)-4,4,5, 5-teramethylimidazoline-oxyl-3-oxi

10 106 min to 18 s; another NO scavenger, 2-(4-carboxyphenyl)-4,4,5, 5-tetramethylimidazoline-1-oxyl-3-

11 ethyl)-isothiourea) or a NO scavenger ([2-(4-carboxyphenyl)-4,4,5, 5-tetramethylimidazoline-1-oxyl-3-

12 ate/ferrous sulfate mixture (MGD-Fe) or 2-(4-carboxyphenyl)-4,4,5, 5-tetramethylimidazoline-1-oxyl-3-

13 glutathione but not by the NO scavenger 2-(4-carboxyphenyl)-4,4,5,5 tetramethylimidazoline 1-oxyl 3-o

14 as the NO inhibitors aminoguanidine and 2-(4-carboxyphenyl)-4,4,5,5-tetra-methylimidazoline-1-oxyl-3-

15 hibitor aminoguanidine and NO scavenger 2-(4-carboxyphenyl)-4,4,5,5-tetramethyl-imidazoline-1-oxyl-3-

16 , a nonspecific DA receptor blocker, or 2-(4-carboxyphenyl)-4,4,5,5-tetramethyl-imidazoline-1-oxyl-3-

17 treatment of rats with the NO scavenger 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazole-1-oxyl-3-oxi

18 of NO with nitronyl nitroxides such as 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl 3-o

19 tion of the nitric oxide (NO) scavenger 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-o

20 ease at 2, 3, and 12 h was inhibited by 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-o

21 , as well as with the scavengers of NO, 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-o

22 ctor-kappaB (NF-kappaB) activation, and 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-o

23 The NO scavengers 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-o

24 on of NO production by the NO scavenger 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-o

25 Either a scavenger of NO [2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-o

26 prevented by the nitric oxide scavenger 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-o

27 irmed by the addition of the NO scavenger 2-(carboxyphenyl)-4,4,5,5-tetramethyllimidazoline-1-oxyl 3-

28 Pretreatment with 2-(4-carboxyphenyl)-4,5-dihydro-4,4,5,5-tetramethyl-1H-imidaz

29 -1-carboxylate (SHCHC) is converted to 4-(2'-carboxyphenyl)-4-oxobutyrate (o-succinylbenzoate or OSB)

30 ersion of o-succinylbenzoic acid [OSB; 4-(2'-carboxyphenyl)-4-oxobutyric acid], to o-succinylbenzoyl-

31 shed in the presence of the NO scavenger 2-4-carboxyphenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-ox

32 ncing, and changes induced by GSNO, GSNO/2-4-carboxyphenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-ox

33 On theoretical grounds, 2-4-carboxyphenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-ox

34 use of (*)NO donors, the scavenger CPTIO ([4-carboxyphenyl]-4,5-dihydro-4,4,5,5-tetramethyl-3-oxide),

35 of an organic tracer dye, rhodamine B ([9-(2-carboxyphenyl)-6-diethylamino-3-xanthenylidene]-diethyla

36 em antibiotic, [4R,5S,6S]-3-[[(3S,5S)-5-[[(3-Carboxyphenyl)amino]carbonyl]-3-pyrrolidinyl ]thio]-6-[(

37 include p-thiolphenyl aminomannose (PTAM), p-carboxyphenyl aminomannose (PCAM), 1-deoxy-1-aminomannop

38 he presence of small amounts of 1,3,5-tris(4-carboxyphenyl)benzene (H(3)BTB) leads to a new crystalli

39 [In3O(btb)2(HCOO)(L)], (H3btb = 1,3,5-tris(4-carboxyphenyl)benzene acid, L = methanol, water, or etha

40 s has been synthesized from 1,2,4,5-tetrakis(carboxyphenyl)benzene and trans-1,2-dipyridylethene stru

41 of the tetratopic ligand 1,2,4,5-tetrakis(4-carboxyphenyl)benzene as a key building block, a permane

42 sequential deposition of 1,2,4,5-tetrakis(4-carboxyphenyl)benzene to form supramolecular heterostruc

43 n acyl-enzyme intermediate with (i) the meta-carboxyphenyl cephalothin analogue and (ii) the carbapen

44 ructed by first electrochemically reducing 4-carboxyphenyl diazonium salt, which had been electrochem

45 oamylnitrite resulting in the formation of 4-carboxyphenyl-DWCNTs.

46 Both Zn2(TCPE) (TCPE = tetrakis(4-carboxyphenyl)ethylene) and Mg(H2DHBDC) (H2DHBDC(2-) = 2

47 2,4-Diamino-[2'-methoxy-5'-(3-carboxyphenyl)ethynylbenzyl]pyrimidine (28), with an IC(

48 c and Tg DHFR, 2,4-diamino-[2'-methoxy-5'-(4-carboxyphenyl)ethynylbenzyl]pyrimidine (29), with the ca

49 anti-TGF antibodies were immobilized onto 4-carboxyphenyl-functionalized SPCEs modified with strepta

50 mate receptor antagonist (RS)-alpha-methyl-4-carboxyphenyl-glycine (MCPG).

51 lography was used to design and evaluate new carboxyphenyl-glycylboronic acid transition-state analog

52 ich the substituent at the 5'-position was a carboxyphenyl group linked to the benzyl moiety by a bri

53 , bpy is 2,2'-bipyridyl and PICH(2) is (2-(4-carboxyphenyl)imidazo[4,5-f][1,10]phenanthroline).

54 MF)(69)(NO(3))(2)](n) (1) {H(2)L = 1,3-bis(4-carboxyphenyl)imidazolium}, has been synthesized under s

55 The 4-carboxyphenyl isomer of 1, in which the carboxylic acids

56 istry between the carboxylic groups of the 4-carboxyphenyl layer and amine groups of the antibody.

57 ochemically generated in situ, to a stable 4-carboxyphenyl layer on carbon nanofiber-modified screen

58 4-carboxyphenyl layers were covalently grafted on the six

59 nal monomer, cytosine-bis(2,2'-bithienyl)-(4-carboxyphenyl)methane ester (Cyt-S4), revealed Watson-Cr

60 tagonist, LY382884 ((3S, 4aR, 6S, 8aR)-6-((4-carboxyphenyl)methyl-1,2,3,4,4a,5,6,7,8,8a-decahydro iso

61 th the antagonist (alphaS)-alpha-amino-3-[(4-carboxyphenyl)methyl]-3,4-dihydro-2,4-dioxo-1(2H)-pyri m

62 s, a chiral cephalothin analogue with a meta-carboxyphenyl moiety corresponding to the C(3)/C(4) carb

63 2P), and Zn(II)-5,10,15,20-tetra(3-ethynyl(4-carboxyphenyl)phenyl)porphyrin (m-ZnTC(PEP)P)) were comp

64 rin (m-ZnTCPP), Zn(II)-5,10,15,20-tetra(3-(4-carboxyphenyl)phenyl)porphyrin (m-ZnTCP2P), and Zn(II)-5

65 rboxyl groups of (R,R)-N,N'-phthaloyl-2,3-(2-carboxyphenyl)-phenyl-3,4-diazaphospholane (1) yields ph

66 hosphorescence quenching of Pd-meso-tetra-(4-carboxyphenyl) porphine by oxygen.

67 g of the phosphorescence of Pd-meso-tetra (4-carboxyphenyl) porphine were determined as a function of

68 on constants determined for Pd-meso-tetra (4-carboxyphenyl) porphine, as measured by two independent

69 The oxygen-sensitive dye, Pd-meso-tetra (4-carboxyphenyl) porphine, bound to bovine serum albumin,

70 hosphorescence quenching of Pd-meso-tetra-(4-carboxyphenyl) porphine, in an airtight chamber that hel

71 hosphorescence quenching of Pd-meso-tetra-(4-carboxyphenyl)porphine by oxygen.

72 Iron(III) meso-tetra(2-carboxyphenyl)porphine chloride (1) was investigated as

73 For a single-molecule zinc-tetra (4-carboxyphenyl) porphyrin (ZnTCPP)/TiO(2) nanoparticle sy

74 ectron-cation recombination in zinc-tetra (4-carboxyphenyl) porphyrin (ZnTCPP)/TiO(2) nanoparticle sy

75 -thienyl)cyclopentene (BPMTC) and tetrakis(4-carboxyphenyl)porphyrin (H4TCPP) ligands anchored by Zn(

76 phyrin (p-ZnTCPP), Zn(II)-5,10,15,20-tetra(3-carboxyphenyl)porphyrin (m-ZnTCPP), Zn(II)-5,10,15,20-te

77 Zn(II)-porphyrins (Zn(II)-5,10,15,20-tetra(4-carboxyphenyl)porphyrin (p-ZnTCPP), Zn(II)-5,10,15,20-te

78 Aggregates of the diacid form of tetra(p-carboxyphenyl)porphyrin (TCPP) are found to be stabilize

79 Via our strategy, tetratopic tetrakis(4-carboxyphenyl)porphyrin (TCPP) ligands were successfully

80 of H(2)TCPP(2+), the diacid form of tetra(p-carboxyphenyl)porphyrin (TCPP).

81 new phosphors, one based on Pd-meso-tetra-(4-carboxyphenyl)porphyrin and the other on Pd-meso-tetra-(

82 talyst was cobalt meso-5,10,15,20-tetrakis(4-carboxyphenyl)porphyrin chloride, Co(TCPP)Cl.

83 cked monolayer of zinc 5,10,15,20-tetrakis(3-carboxyphenyl)porphyrin has been prepared and deposited

84 based signal amplification method to tetra(4-carboxyphenyl)porphyrin nanoparticles (TCPP NPs).

85 dicarboxydiphenyl sulfone, TCPP = tetrakis(4-carboxyphenyl)porphyrin).

86 udies of the uroporphyrin:Cc and tetrakis (4-carboxyphenyl)porphyrin:Cc complexes suggests that side-

87 ganic framework consisting of [5,10,15,20-(4-carboxyphenyl)porphyrin]Co(III) (CoTCPP) struts bound by

88 Four Zn(II)-tetra(carboxyphenyl)porphyrins in solution and bound to metal

89 he broad-range iGluR antagonist (2S,3R)-3-(3-carboxyphenyl)pyrrolidine-2-carboxylic acid (1) by explo

90 The 3-carboxyphenyl ring of 2e and 2f forms contacts comparabl

91 have prepared ruthenium complexes with 4'-(4-carboxyphenyl)terpyridine ligands, and studied reactivit

92 )porphyrin and the other on Pd-meso-tetra-(4-carboxyphenyl)tetrabenzoporphyrin, are very well suited

93 erts p-aminobenzoate (Ar-NH(2), where Ar = 4-carboxyphenyl) to p-nitrobenzoate (Ar-NO(2)) in the bios

94 c-ring-dihydroxylated CBZ (VI) and N,N-bis(2-carboxyphenyl)urea (VII).

95 In contrast, the (3-carboxyphenyl)urea derivative (29, GW7854) had moderatel

96 ex, symmetrical bis-benzimidazoles and a bis-carboxyphenyl were then assayed as fragment-based leads,

97 The optimal N3 substituent had m-carboxyphenyl with a two-carbon alkyl tether.

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。